U.S. Biliary Stents Market by Type (Metal Biliary stents, and Plastic Biliary stents), Application (Malignant Obstruction, Benign Biliary Strictures, Biliary Leaks, and Others), and End User (Hospitals, and Ambulatory Surgical Centers): Opportunity Analysis and Industry Forecast, 2018 - 2025
- ALL2963651
- 100 Pages
- March 2019
- Medical Devices
The significant rise in the prevalence of pancreatic cancer and other biliary diseases across the U.S. is one of the major factors that drives the biliary stents market. For instance, according to the American Cancer Society (2019), pancreatic cancer accounts for about 3% of all cancers in the U.S. and about 7% of all cancer deaths. In addition, technological advancements associated with biliary stents and surge in demand for minimally invasive procedures further contributes to the market growth.
Although the U.S. biliary stents market continues to grow, certain factors hamper the growth of this market. The complications and high costs associated with biliary stents are anticipated to hamper the market growth. Conversely, development of innovative smartphone applications leading to better adoption and opportunities in the emerging economies are anticipated to offer growth opportunities for the U.S. biliary stents market.
The U.S. biliary stent market is segmented based on type, application, and end user. Based on type, it is categorized into biliary metal stents, and biliary plastic stents. Based on application, the market is categorized into malignant obstruction, benign biliary strictures, biliary leaks, and others. Based on end user, it is divided into hospitals and ambulatory surgical centers. The major companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Conmed Corporation, Cook Medical, B. Braun Melsungen AG, Medtronic plc, Terumo Corporation, Merit Medical, Olympus Corporation, and Becton, Dickinson and Company. The other players included in the value chain analysis (but not included in the report) are Taewoong Medical Co., Ltd., Biosensors International Group, Ltd., and others.
Key Benefits for Stakeholders
• The report provides an extensive analysis of the current market trends and future estimations of the U.S. biliary stents market.
• The U.S. biliary stents market top player positioning is comprehensively analyzed in the report.
• The U.S. biliary stents market share is comprehensively analyzed with respect to the application, type, and end user.
• U.S. biliary market growth analysis by type helps understand the significance of the different types of biliary stents available in the market.
• Key manufacturers involved in the U.S. biliary stents market are listed and analyzed in this report to understand the competitive scenario of the market.
Key Market Segments
• By Type
o Metal biliary stents
o Plastic biliary stents
• By Application
o Malignant obstruction
o Benign biliary strictures
o Biliary leaks
o Others
• By End User
o Hospitals
o Ambulatory surgical centers
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.3.1. List of players profiled in the report
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Chapter: 2: EXECUTIVE SUMMARY
2.1. Key Findings of the Study
2.2. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Porter’s five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. High prevalence of biliary diseases
3.5.1.2. Technological advancements associated with biliary stents and urge in demand for minimally invasive procedures
3.5.2. Restraint
3.5.2.1. Complications and high costs associated with biliary stents
3.5.3. Opportunity
3.5.3.1. Development of innovative smartphone applications
Chapter: 4: U.S. BILIARY STENTS MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Metal Biliary Stents
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Plastic Biliary Stents
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
Chapter: 5: U.S. BILIARY STENTS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Malignant obstruction
5.2.1. Market size and forecast
5.3. Benign biliary strictures
5.3.1. Market size and forecast
5.4. Biliary leaks
5.4.1. Market size and forecast
5.5. Others
5.5.1. Market size and forecast
Chapter: 6: U.S. BILIARY STENTS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast
6.3. Ambulatory surgical centers
6.3.1. Market size and forecast
Chapter: 7: COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. BECTON, DICKINSON AND COMPANY
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.4. BOSTON SCIENTIFIC CORPORATION
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.5. COOK MEDICAL INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.6. CONMED CORPORATION
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Product portfolio
7.7. MEDTRONIC PLC
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. MERIT MEDICAL SYSTEMS, INC.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. OLYMPUS CORPORATION
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. TERUMO MEDICAL CORPORATION
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
TABLE 01. U.S. BILIARY STENTS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 02. U.S. BILIARY STENTS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 03. U.S. BILIARY STENTS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 04. ABBOTT: COMPANY SNAPSHOT
TABLE 05. ABBOTT: OPERATING SEGMENTS
TABLE 06. ABBOTT: PRODUCT PORTFOLIO
TABLE 07. B. BRAUN: COMPANY SNAPSHOT
TABLE 08. B. BRAUN: OPERATING SEGMENTS
TABLE 09. B. BRAUN: PRODUCT PORTFOLIO
TABLE 10. BD: COMPANY SNAPSHOT
TABLE 11. BD: OPERATING SEGMENTS
TABLE 12. B. BRAUN: PRODUCT PORTFOLIO
TABLE 13. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 14. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 15. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 16. COOK MEDICAL: COMPANY SNAPSHOT
TABLE 17. COOK MEDICAL: OPERATING SEGMENTS
TABLE 18. COOK MEDICAL: PRODUCT PORTFOLIO
TABLE 19. CONMED CORPORATION: COMPANY SNAPSHOT
TABLE 20. CONMED CORPORATION: OPERATING SEGMENTS
TABLE 21. CONMED: PRODUCT PORTFOLIO
TABLE 22. MEDTRONIC: COMPANY SNAPSHOT
TABLE 23. MEDTRONIC: OPERATING SEGMENTS
TABLE 24. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 25. MERIT: COMPANY SNAPSHOT
TABLE 26. MERIT: OPERATING SEGMENTS
TABLE 27. MERIT: PRODUCT PORTFOLIO
TABLE 28. OLYMPUS CORPORATION.: COMPANY SNAPSHOT
TABLE 29. OLYMPUS CORPORATION.: OPERATING SEGMENTS
TABLE 30. OLYMPUS CORPORATION.: PRODUCT PORTFOLIO
TABLE 31. TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 32. TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 33. TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
